A Phase I-II Pharmacokinetic Drug-Drug Interaction Evaluation of Oral Palbociclib in Combination with Vemurafenib in Patients Suffering Metastatic Melanoma with BRAF V600 Mutated and CDKN2A Loss & Expression of Rb
Experimental and Molecular Therapeutics（2019）
Key words
Metastatic Breast Cancer,Palbociclib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined